Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Category

Sub-category

Conference

Cytoreductive nephrectomy for mRCC treated with immune checkpoint inhibitors or...

Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA

Cytoreductive nephrectomy for mRCC treated with immune checkpoint inhibitors or targeted therapy ( Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA )

NEO-BLADE: Nintedanib or placebo with gemcitabine and cisplatin in locally...

Dr Syed Hussain - University of Sheffield, Sheffield, United Kingdom

NEO-BLADE: Nintedanib or placebo with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer ( Dr Syed Hussain - University of Sheffield, Sheffield, United Kingdom )

NIVOREN: Nivolumab in a 'real world setting' for metastatic clear-cell renal...

Dr Yann-Alexandre Vano - Hôpital Européen Georges-Pompidou, Paris, France

NIVOREN: Nivolumab in a 'real world setting' for metastatic clear-cell renal cell carcinoma ( Dr Yann-Alexandre Vano - Hôpital Européen Georges-Pompidou, Paris, France )

OSPREY: PSMA-targeted PET/CT imaging in prostate cancer patients

Dr Frédéric Pouliot - Centre Hospitalier Universitaire (CHU) de Quebec

OSPREY: PSMA-targeted PET/CT imaging in prostate cancer patients ( Dr Frédéric Pouliot - Centre Hospitalier Universitaire (CHU) de Quebec )

ASCO GU 2020: Bladder: Genomic profiling, real-world treatment challenges and...

Dr Petros Grivas, Dr Shilpa Gupta, Dr Alison Birtle and Dr Joseph Jacob

ASCO GU 2020: Bladder: Genomic profiling, real-world treatment challenges and novel agents ( Dr Petros Grivas, Dr Shilpa Gupta, Dr Alison Birtle and Dr Joseph Jacob )

Sitravatinib and nivolumab combo for advanced clear cell renal cell cancer

Dr Pavlos Msaouel - The University of Texas MD Anderson Cancer Center, Houston...

Sitravatinib and nivolumab combo for advanced clear cell renal cell cancer ( Dr Pavlos Msaouel - The University of Texas MD Anderson Cancer Center, Houston, USA )

BLASST-1: Combining nivolumab, gemcitabine and cisplatin for the neoadjuvant...

Dr Shilpa Gupta - Case Comprehensive Cancer Center, Cleveland, USA

BLASST-1: Combining nivolumab, gemcitabine and cisplatin for the neoadjuvant treatment of muscle invasive bladder cancer ( Dr Shilpa Gupta - Case Comprehensive Cancer Center, Cleveland, USA )

Management of patients with advanced seminoma

Prof Peter Albers - Düsseldorf University, Düsseldorf, Germany

Management of patients with advanced seminoma ( Prof Peter Albers - Düsseldorf University, Düsseldorf, Germany )

CHHip: Conventional versus hypofractionated high-dose intensity modulated...

Prof David Dearnaley - Institute of Cancer Research, London, UK

$CHHip: Conventional versus hypofractionated high-dose intensity modulated radiotherapy for localised prostate cancer ( Prof David Dearnaley - Institute of Cancer Research, London, UK )$

Latest advances in mHSPC from ASCO GU 2020

Dr Eleni Efstathiou and Prof Axel Merseburger

Latest advances in mHSPC from ASCO GU 2020 ( Dr Eleni Efstathiou and Prof Axel Merseburger )

ASCO GU 2020: Updates in renal cancer

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

ASCO GU 2020: Updates in renal cancer ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

Beyond p-values: When does clinical impact outweigh statistical significance?

Prof Matthew Sydes - University College London, London, UK

Beyond p-values: When does clinical impact outweigh statistical significance? ( Prof Matthew Sydes - University College London, London, UK )

More from ecancer